ロード中...
Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients
BACKGROUND: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide due to poor patient prognosis and clinical outcome. Here, we studied the genetic variations underlying NSCLC pathogenesis based on their association to patient outcome after gemcitabine therapy. RESULTS...
保存先:
出版年: | BMC Genomics |
---|---|
主要な著者: | , , , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4290611/ https://ncbi.nlm.nih.gov/pubmed/25521664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-15-S9-S20 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|